Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lebrikizumab in Adult Patients With Mild to Moderate Asthma
NCT02104674Phase 3Completed
- Sponsor
- Roche
- Start
- Jun 2014
- Primary completion
- Jan 2016
- Modality
- Monoclonal Antibodies
- Countries
- 11
01
Overview
A Phase 3 trial of lebrikizumab in asthma, sponsored by Roche. Started Jun 2014; status: completed.
02
Drugs
lebrikizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02104674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104674.